Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Aardvark Therapeutics, Inc. (AARD)

NASDAQ

$5,05

$-0,51

(-9,19%)

Pre-Market

Aardvark Therapeutics, Inc. (AARD) Live Price Chart

Last updated: ⁦2026-09-16 09:45:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Aardvark Therapeutics, Inc. (AARD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5,05, with a market capitalisation of $121,46M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,35 to $17,94. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$121,46M
Open	$5,47
Day's High	$19,58
Day's Low	$3,35
Previous Close	$5,55
Volume	61,02K
Average Volume	254,22K
P/E Ratio	--
52-Week High	$17,94
52-Week Low	$3,35
Dividend Yield	--
Earnings Date	--

Aardvark Therapeutics, Inc. (AARD) Pre-Market Stock Price

Aardvark Therapeutics, Inc. (AARD) is trading at $5,64 in pre-market trading as of 2026-09-15 23:31:00, up 1,53% ($0,08) from the previous close of $5,55

Pre-market trading shows how investors are pricing AARD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Aardvark Therapeutics, Inc. (AARD) 7-Day Stock Price Change

Over the past seven days, Aardvark Therapeutics, Inc. (AARD) moved from $5,38 to $5,05, representing a decline of 6,08% ($0,33).

The stock traded between $4,54 and $5,99 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 185,64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

AARD 52-Week Price Position

Position in Range: 11,7%

52W Low$3,35

52W High$17,94

AARD is currently trading at $5,05, placing it 11,7% of the way from its 52-week low of $3,35 to its 52-week high of $17,94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aardvark Therapeutics, Inc. (AARD)?

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Aardvark Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	28
Exchange	NASDAQ
Company Website	https://www.aardvarktherapeutics.com

How to Buy Aardvark Therapeutics, Inc. (AARD) Stock on MEXC

Eligible investors can buy real shares of Aardvark Therapeutics, Inc. (AARD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AARD and Place Your Order

Open the RealStocks trading page and search for AARD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aardvark Therapeutics, Inc. (AARD) stock price today?

Aardvark Therapeutics, Inc. (AARD) is currently trading at $ 5,05, down 8,95% ($0,50) from the previous close of $ 5,55. Intraday prices update in real time during regular trading hours.

2.Is AARD stock going up or down today?

As of 2026-09-15 23:31:00, AARD is trading at $ 5,05, down 8,95% ($0,50) from its previous close of $ 5,55. The stock has traded between $ 3,35 and $ 19,58 during today’s regular session. Past price movements do not guarantee future results.

3.What is AARD pre-market price?

As of 2026-09-15 23:31:00, AARD is trading at $ 5,64 in pre-market trading, up 1,53% ($0,08) from the previous close of $ 5,55. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AARD after-hours price?

As of 2026-09-15 23:31:00, AARD is trading at $ 5,06 in after-hours trading, down 8,92% ($0,50) from the regular-session close of $ 5,55. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AARD stock trading now?

AARD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AARD sit relative to its 52-week high and low?

Over the past 52 weeks, AARD has traded between a low of $ 3,35 and a high of $ 17,94. At $ 5,05, the stock is positioned 11,7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aardvark Therapeutics, Inc. in?

Aardvark Therapeutics, Inc. (AARD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aardvark Therapeutics, Inc.'s market capitalisation and where is it listed?

Aardvark Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 121,46M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AARD valued in terms of P/E ratio and EPS?

AARD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3,19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aardvark Therapeutics, Inc. pay a dividend?

Aardvark Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.